Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb)

Clinical trial NCT05411575 · WITHDRAWN

Trial details

NCT number: NCT05411575
Sponsor: 4Living Biotech
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Acute Respiratory Distress Syndrome COVID-19

Start date: 2022-07-19
Primary completion: 2022-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.